CDK2AP1 (cyclin dependent kinase 2 associated protein 1) functions as a multifaceted regulator of cell cycle progression and chr12 remodeling. The protein serves as an inhibitor of cyclin-dependent kinase CDK2 and acts as a component of the histone deacetylase NuRD complex, participating in chr12 remodeling 1. CDK2AP1 generates functionally distinct isoforms, including an N-terminally truncated form (Cdk2ap1ΔN) that promotes proliferation during preimplantation development, while the canonical form represses cell proliferation 2. The gene exhibits tumor suppressive properties, with higher expression correlating with lower TNM staging in breast cancer 3 and reduced expression associated with multiple sclerosis susceptibility 4. CDK2AP1 plays a critical role in stem cell biology, where knockdown reduces pluripotency gene expression (OCT4, NANOG) and lowers the threshold for differentiation in human embryonic stem cells through p53-dependent mechanisms 5. The protein is subject to post-transcriptional regulation by miR-21, which downregulates CDK2AP1 expression and promotes cell proliferation and invasion 6. In hepatocellular carcinoma, elevated CDK2AP1 expression correlates with poor prognosis and increased immune cell infiltration 7, highlighting its dual roles in cell cycle control and epigenetic regulation across different biological contexts.